TET1 and obesity due to melanocortin 4 receptor deficiency: Our new data suggests, potentially for the first time, that two distinct physiological hallmarks of obesity—systemic hyperglycemia and chronic inflammation—might converge on this TET1-driven pathway to drive cancer stem-like cell induction.